鲍曼不动杆菌所致呼吸机相关性肺炎患者血清IL-17 IL-35水平及与预后关系

doi:10.3969/j.issn.1006-6233.2020.06.011

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1235 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To detect the levels of IL-17 and IL-35 in patients with ventilator-associated pneumonia (VAP) caused by Acinetobacter baumannii (AB), and to study the connection between them and the prognosis. Methods: 127 patients with VAP caused by AB in Shenzhen People's Hospital from July 2016 to October 2018 were selected as the subjects for the retrospective analysis. According to the 30-day survival of patients, they were divided into survival group (84 cases) and death group (43 cases). The general data of the two groups were collected and compared, which include:the levels of IL-17 and IL-35 in serum were detected by enzyme-linked immunosorbent assay (ELISA); T lymphocyte subsets were detected by flow cytometry; Pearson method was used to analyze the correlations between IL-17, IL-35 and T lymphocyte subsets, APACHE II score; Logistic analysis was used to analyze the factors influencing the prognosis of VAP patients caused by AB. Results: There was no significant difference in gender, age, time of tracheotomy, incision size and intraoperative hemorrhage between the two groups (P > 0.05); compared with the survival group, the APACHE II score, the levels of IL-17, IL-35 and CD8+ T lymphocyte in the dead group increased (P < 0.05); the levels of CD3+ T, CD4+ T lymphocytes and the ratio of CD4+/CD8+ decreased (P < 0.05). Pearson analysis showed that IL-17 and IL-35 were negatively correlated with CD3+ T, CD4+ T and CD4+/CD8+ (P < 0.05), and positively correlated with CD8+ T and APACHE II score (P < 0.05). The IL-17, IL-35 and APACHE II score were the risk factors for the prognosis of VAP induced by AB, and CD4+/CD8+ was the protective factor for the prognosis of VAP induced by AB. Conclusions: The increase of the levels of IL-17 and IL-35 in VAP patients is closely related to immune function factors, which is the risk factor for death. They can be used as indicators to predict the prognosis of VAP patients induced by AB.

Key words： Acinetobacter baumannii Ventilator-associated pneumonia Interleukin-17 Interleukin-35 Prognosis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LUO Yutian
	LV Changyan
	XIE Yisong
	et al

Cite this article:

LUO Yutian,LV Changyan,XIE Yisong, et al. Analysis of the Levels of Serum IL-17 IL-35 in Patients with Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii and Their Connection with Prognosis[J]. HeBei Med, 2020, 26(6): 932-935.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2020.06.011 OR http://www.hbyxzzs.cn/EN/Y2020/V26/I6/932

[1] Lee P L, Lee W T, Chen H L. Ventilator-associated pneumonia in low birth weight neonates at a neonatal intensive care unit: a retrospective observational study[J]. Pediatr Neonatol, 2017, 58(1):16~21.
[2] 陈玺,魏春林.降钙素原、白细胞介素-17和可溶性髓系细胞触发受体1水平的检测在机械通气并呼吸机相关性肺炎患者中的意义[J].内科急危重症杂志,2019,25(4):309~312.
[3] 王红民,张小红,叶立群,等.白细胞介素-35调控CD4＋CD25＋CD127dim/-调节性T细胞在呼吸机相关性肺炎发病中的作用[J].中华微生物学和免疫学杂志,2017,37(9):674~681.
[4] 中华医学会重症医学分会.呼吸机相关性肺炎诊断、预防和治疗指南(2013)[J].中华内科杂志,2013,52(6):524~543.
[5] 陈熙.优化个体护理对ICU重症肺炎患者APACHEⅡ评分及相关生理指标的影响[J].实用临床医药杂志,2016,20(16):28~30.
[6] Othman H A, Gamil N M, Elgazzar A E M, et al. Ventilator associated pneumonia, incidence and risk factors in emergency intensive care unit Zagazig university hospitals[J]. Egypt Chest Dis Tuberc, 2017, 66(4):703~708.
[7] Robinson C, Hoze M, Hevener S, et al. Development of an RN champion model to improve the outcomes of ventilator-associated pneumonia patients in the intensive care unit[J].Nurs Adm, 2018, 48(2):79~84.
[8] 郝东侠,王伟,刘伟,等.综合ICU内耐碳青霉烯鲍曼不动杆菌相关呼吸机相关性肺炎的危险因素分析[J].中国临床医生杂志,2017,45(12):29~31.
[9] Kun M, Yu C, Jing WZ,et al. The evaluation of cellular immune function in elderly patients with systemic lupus erythematosus[J]. Korean Intern Med, 2017, 34(4):932~937.
[10] Carmona P, Medina AY, Cabral A,et al. Regulatory/inflammatory cellular response discrimination in operational tolerance[J]. Nephrol Dial Transplan, 2019, 5(9):114~118.
[11] 梁小芳,杨名,和义敏,等.IL-35的生物学特性及其在自身免疫性疾病治疗中的新进展[J].华中科技大学学报(医学版),2019,48(4):477~481.
[12] Cheng S T, Yuan D, Liu Y, et al. Interleukin-35 level is elevated in patients with chronic hepatitis B virus infection[J]. Int Med Sci, 2018, 15(2):188~194.
[13] Yang Z, Xian T, Ying-Xia L, et al. Immune function of IL-35,IL-17 in mixed disease of human immunodeficiency virus infection and tuberculosis[J]. Modern Med, 2015,43(1):16~20.
[14] 陈少艳,刘基铎,肖明峰,等.淋巴细胞亚群检测在感染性疾病中的应用[J].国际检验医学杂志,2017,38(2):206~208.
[15] 苗军,任瑞英,刘海燕.带状疱疹和疱疹后神经痛外周血T淋巴细胞亚群计数与细胞因子表达水平的变化[J].脑与神经疾病杂志,2019,27(7):410~414.